Abstract The AcmA binding domains of Lactococcus lactis were used to display the VP1 protein of chicken anemia virus (CAV) on Lactobacillus acidophilus. One and two repeats of the cell wall binding domain of acmA gene were amplified from L. lactis MG1363 genome and then inserted into co-expression vector, pBudCE4.1. The VP1 gene of CAV was then fused to the acmA sequences and the VP2 gene was cloned into the second MCS of the same vector before transformation into Escherichia coli. The expressed recombinant proteins were purified using a Histag affinity column and mixed with a culture of L. acidophilus. Whole cell ELISA and immunofluorescence assay showed the binding of the recombinant VP1 protein on the surface of the bacterial cells. The lactobacilli cells carrying the CAV VP1 protein were used to immunize specific pathogen-free chickens through the oral route. A moderate level of neutralizing antibody to CAV was detected in the serum of the immunized chickens. A VP1-specific proliferative response was observed in splenocytes of the chickens after oral immunization. The vaccinated groups also showed increased levels of Th1 cytokines interleukin (IL)-2, IL-12, and IFN-γ. These observations suggest that L. acidophilus can be used in the delivery of vaccines to chickens.
Introduction
The oral administration of vaccines has some advantages over other routes. Oral immunization is convenient, relatively inexpensive, easy boosting, and can be carried out on a large scale. Furthermore, oral immunization has the capacity to induce immunity in the mucosal surface, where many viral and bacterial pathogens enter the body. Two main live bacterial delivery systems, either using genetically attenuated strains of pathogenic bacteria such as Salmonella sp. (Dertzbaugh 1998) and Mycobacterium (Stover et al. 1993) or using commensal or food-grade bacteria such as lactic acid bacteria (LAB), especially lactococci and lactobacilli (Zegers et al. 1999; Maggi et al. 2000; Lee et al. 2001; Ribeiro et al. 2002; Scheppler et al. 2002; Dieye et al. 2003) have been developed for oral immunization purposes. As live delivery vehicles, LABs are safer alternatives to live attenuated pathogens due to their GRAS status and long history of use in the production of fermented food.
The number of studies on oral immunization in chickens is very limited. One example is a report by Dieye et al. (2003) in which Lactococcus lactis was used as live mucosal vaccine against chicken infectious bursal disease virus (IBDV). They reported the development of a lactococcal system for expressing and targeting the IBDV antigenic proteins, VP2 and VP3 to the cytoplasm, the cell wall, or the extracellular compartment of L. lactis. However, no immune response was detected to the IBDV VP2 and VP3 proteins in the immunized chickens.
In the present study, the development of a novel oral vaccine against chicken anemia virus (CAV) in chicken using CAV VP1-carrying lactobacilli as live delivery vehicle has been reported. The binding domain of AcmA anchor motif of L. lactis was used to display the VP1 protein of CAV on the surface of the lactobacilli cells. AcmA, N-acetylmuramidase (Fig. 1a) , is the major autolysin of L. lactis cell wall, consisting of an N-terminal active site domain and a C-terminal peptidoglycan-binding domain contains three repeats of 44 amino acids which are involved in cell wall binding (Buist et al. 1995) . Only one of these repeats is sufficient for cell wall binding (Buist 1997; Raha et al. 2005) . The AcmA binding domain of L. lactis has been shown to be able to bind to the cell wall of a range of Grampositive bacteria, including Lactobacillus, Clostridium, Listeria, and Bacillus, when added from the outside (Buist 1997; Raha et al. 2005; Okano et al. 2008) . Raha et al. (2005) reported that the VP1 protein of enterovirus 71 linked to one repeat of AcmA binding domain purified from a recombinant Escherichia coli can be successfully bound on the surface of L. lactis, Lactobacillus plantarum, and Bacillus sphericus by mixing it with the live cells. This E. coli expression-based system was chosen to be used to produce and display the antigen-anchor fusion proteins on the cell surface of L. acidophilus.
Material and methods

Microorganisms and vectors
L. lactis MG1363 was used for the amplification of the acmA gene. Lactobacillus acidophilus (ATCC 53672) was used as carrier for viral proteins. E. coli BL21 (DE3) was the strain used as the expression host cell. The pETDuetTM-1 (Novagen, Germany) vector was used for the construction of the recombinant plasmids. The pETDuetTM-1 contains two multiple cloning sites (MCS), each of which is preceded by a T7 promoter/lac operator and a ribosome binding site. The Malaysian CAV isolate SMSC-1 (GenBank accession no. AF285882) and recom- Fig. 1 a Schematic illustration of the AcmA protein. The AcmA protein consists of two domains, an N-terminal catalytic domain including signal peptide (S.P.) and an active site (A.S.), and a Cterminal anchoring domain. The anchoring domain contains three repeats (LysM1-3) that are highly homologous. b Schematic illustration of the fusion proteins encoding by pETVP1/acmA1 and pETVP1/ acmA2 plasmids. c Map of the recombinant plasmids pETVP1/ acmA1-VP2 and pETVP1/acmA2-VP2. The CAV VP1 gene was inserted into EcoRI and PstI sites of pETacmA1 and pETacmA2 plasmids at upstream of acmA gene to construct pETVP1/acmA1 and pETVP1/acmA2, respectively. The CAV VP2 gene was then cloned into NdeI and XhoI of the MCS2 of pETVP1/acmA1 and pETVP1/ acmA2 plasmids to construct pETVP1/acmA1-VP2 and pETVP1/ acmA2-VP2 binant plasmid pCR(VP1-VP2) containing VP1 and VP2 genes of CAV isolate SMSC-1 (Chowdhury et al. 2003) was obtained from Prof. Abdul Rahman Omar, Faculty of Veterinary Medicine, Universiti Putra Malaysia.
Construction of plasmids pETacmA1 and pETacmA2
One (acmA1) and two repeats (acmA2) of the cell wall binding domain of acmA gene were amplified with the acmA-specific primers listed in Table 1 , using the genomic DNA of L. lactis MG1363 (accession no. LLU17696) as a template. The amplified acmA1 and acmA2 fragments were inserted into the PstI and HindIII sites of the MCS1 of pETDuetTM-1 to construct pETacmA1 and pETacmA2, respectively. The recombinant plasmids were transformed into E. coli BL21 (DE3) by the chemical transformation method (Sambrook and Russell 2001) . The correct orientation of the inserts was analyzed by restriction enzyme analysis and polymerase chain reaction (PCR). The sequence of the genes was confirmed by double-stranded sequencing (Medigene, Malaysia).
Cloning of the VP1 and VP2 genes of CAV The CAV genes, VP1 and VP2, were amplified from the recombinant pCR(VP1-VP2) cloning vector containing VP1 and VP2 genes of CAV isolate SMSC-1 (accession no. AF285882) using the specific primers listed in Table 1 . The VP1 gene was inserted into the EcoRI and PstI sites of the recombinant plasmids, pETacmA1 and pETacmA2 in frame with the acmA gene to constructed pETVP1/acmA1 and pETVP1/acmA2 encoding the fusion proteins VP1/ AcmA1 and VP1/AcmA2 (Fig. 1b) . To construct pETVP1/ acmA1-VP2 and pETVP1/acmA2-VP2, the VP2 gene was cloned into the NdeI and XhoI sites of the MSC2 of pETVP1/acmA1 and pETVP1/acmA2, respectively. After transformation into E. coli and verification of the recombinant plasmids by restriction enzyme analysis and PCR, the sequence of the inserted genes was confirmed by doublestranded sequencing.
The protein expression of the genes was evaluated in the recombinant E. coli BL21 (DE3) containing the DNA plasmid constructs. Briefly, the cells were grown in LB broth supplemented with 50 μg/ml ampicillin until the culture reached OD 600 0.5-0.7. After induction by IPTG at a final concentration of 1 mM, the cells were harvested by centrifugation at 2,000×g for 10 min. The cell pellet was resuspended in 2× sample buffer (1.25 ml Tris-HCl, pH 6.8, 20% glycerol, 4% sodium dodecyl sulfate (SDS), 0.02% (w/v) bromophenol blue, 10% 2-mercaptoethanol) prior to boiling at 95°C for 5 min. Insoluble materials were removed by centrifugation at 10,000×g for 5 min, and the supernatant containing the proteins was used for SDSpolyacrylamide gel electrophoresis (PAGE) analysis. The SDS-PAGE method was carried out according to the Laemmli discontinuous SDS system (Laemmli 1970 ) using 12% polyacrylamide gel. For Western blot analysis, the separated proteins on SDS-PAGE were transferred onto nitrocellulose membrane by semi-dry transfer cell (BioRad, USA). After blocking with 1:10 dilution of skim milk (KPL, USA) in TBS, the membrane was incubated with anti-His monoclonal antibody or chicken anti-CAV (isolate SMSC-1) serum as primary antibody for the detection of the fusion proteins, AcmA1/VP1 and AcmA2/VP1, or monoclonal mouse S-tag antibody for the detection of CAV VP2. The blot was then washed and soaked with either secondary antibody conjugated to alkaline phosphatase for 1 h at room temperature (RT) with gentle agitation. The membrane was further washed and the protein bands were visualized by using developing a solution containing nitro blue tetrazolium, bromochloroindolyl phosphate in alkaline phosphatase buffer.
Purification of the fusion proteins and binding to L. acidophilus
After synchronous expression of the VP1/AcmA1 and VP1/ AcmA2 proteins with the CAV VP2, the fusion proteins were purified by using the Ni-NTA purification system (Invitrogen, USA). After induction, the E. coli cells were harvested; washed with pre-chilled dH 2 O; and then suspended in lysis buffer containing 50 mM NaH 2 PO 4 / Na 2 HPO 4 , 0.1 M NaCl, pH 7.6, 1 mM protease inhibitor phenylmethylsulfonyl fluoride and 0.2 mg/ml lysozyme, followed by 1 h of incubation at 4°C with gentle agitation. The cells were then sonicated using Labsonic U sonicator (B. Braun, Germany) at a power output of 40 W for 10 cycles of 30-s bursts (10×, 30 s), with interval cooling on ice. The crude lysate was centrifuged at 20,000 × g at 4°C for 30 min and the clear supernatant containing soluble proteins was applied onto a Ni 2+ -affinity column (Invitrogen, USA) to purify the proteins. The concentration of the purified proteins was evaluated based on the Bradford method.
The cells in 5 ml of overnight culture of L. acidophilus (ATCC 53672) in MRS broth supplemented with 0.5% glucose (GMRS) (OD 600 of 0.5-0.7) were harvested at 2,000×g for 5 min; resuspended in 600 μl of fresh GMRS broth; and then mixed with 200 μl of the purified proteins (5 mg/ml) followed by 2 h of incubation at 30°C. The cells were precipitated at 2,000×g for 10 min and then washed with 1X phosphate-buffered saline (PBS) three times. The binding was analyzed by ELISA and immunofluorescence microscopy.
To determine the binding stability of the fusion proteins, the cells formerly incubated with the fusion proteins were harvested, and the cell pellets were resuspended in 1.2 ml of 1× PBS. The cell suspensions were stored at 4°C for 5 days and after each 24-h interval, 200 μl of the samples were tested for the presence of the fusion proteins on the cell wall surface by ELISA.
ELISA and immunofluorescence microscopy
After binding procedure, cells were fixed with 4% (w/v) paraformaldehyde for 20 min at RT. The fixed cells were washed with 1x PBS (×3); and then incubated with the blocking solution [3% (w/v) bovine serum albumin (BSA) in 1x PBS] for 30 min at RT followed by further washing with 1x PBS (×3). The cells were then incubated with 500 μl of primary chicken anti-CAV serum at a ratio of 1:200 μl in 1% BSA (w/v) for 60 min at RT. The cells were washed with 1x PBS (×3) and then incubated with 500 μl of horseradish peroxidase conjugated anti-chicken antibody diluted at 1:500 in 1% BSA for further 60 min. Following three times washing, the cells were resuspended in 200 μl of 1x PBS. Finally, 10 μl of the suspension and 50 μl of substrate (BM Blue, Roche) was mixed in the wells of the ELISA plate and then incubated at RT for 20 min. The reaction was stopped by adding 50 μl of stop solution (1 M H 2 SO 4 ) and the absorbance was measured at 490 nm.
Lactobacilli cells incubated with BSA or 1x PBS were used as control.
For immunofluorescence microscopy, the cells mixed with the fusion proteins were placed on chamber slides precoated with poly-L-lysine and air-dried before incubation with 4% (w/v) paraformaldehyde for 20 min at RT. The fixed cells were washed (×3) with 1x PBS; and then incubated with 3% (w/v) BSA in 1x PBS for 30 min at RT to block non-specific binding. The cells were then incubated with chicken anti-CAV serum diluted at a ratio of 1:200 in 1% BSA, followed by incubation at RT for 60 min. After washing three times with 1x PBS, the cells were incubated with FITC anti-chicken IgY diluted at 1:200 in 1% BSA at RT for 1 h. Following washing with 1x PBS (×3), the slide was air-dried and then analyzed by an inverted phase contrast microscope with fluorescence light.
Oral immunization of SPF chickens
The 3-week-old specific pathogen-free (SPF) chickens were divided into four groups (n=10). Groups 1 and 2 were orally fed with 10 9 cells of L. acidophilus carrying VP1/ AcmA1 or VP1/AcmA2 protein, respectively. As control, chickens in groups 3 and 4 were fed with 10 9 cells of normal L. acidophilus not incubated with the fusion proteins or 1 ml of 1x PBS (pH 7.4), respectively. The feeding strategy was obtained (with some modification) from the report by Dieye et al. (2003) in which L. lactis was used as live vehicle for mucosal delivery of infectious bursal disease virus antigens in chickens. At the age of 21, the chickens were fed for five consecutive days. At the age of 35 days, chickens again were fed for another five consecutive days. Blood samples were taken from the chickens when they were 21, 35, and 46 days old. The collected sera were stored at −20°C for further analysis. All procedures were conducted with the protocols approved by the Animal Care and Use Committee of the Faculty of Veterinary Medicine, Universiti Putra Malaysia.
Antibody response after oral immunization
Serum antibody titer against CAV was determined using the IDEXX ELISA kit (IDEXX, Portland, ME, USA) at days 21 (before the first feeding), 35 (2 weeks after the first feeding) and 46 (1 week after the second feeding). ELISA was performed according to the procedures recommended by the company. Antibody titers higher than 1,000 were considered positive.
Virus neutralization test
To determine the neutralization antibody titers in the immunized chickens, a virus neutralization (VN) test was carried out in triplets in 96-well microplates by the measurement of cell proliferation and viability using the cell proliferation reagent WST-1 (Roche, Germany) according to the method described by Lehtoranta et al. (2009) with some modifications. Anti-CAV serum was used as positive control. Briefly, twofold serial dilutions of heatinactivated (56°C for 30 min) sera were prepared in RPMI medium to achieve a dilution range from 1:4 to 1:2,048. The diluted sera (50 μl) were transferred into flat bottom 96-well microplates and then mixed with an equal volume of 10 5 TCID50 of CAV SMSC-1 strain. After 60 min of incubation at 39°C, 200 μl MSB-1 (Marek's disease spleen from chickens infected with the BC-1 strain of MDV) cells were added to each well at a concentration of 1.5×10 5 cells per milliliter followed by further incubation at 39°C and 5% CO 2 for 5 days. The RPMI medium with virus (non-neutralized virus) and or with positive anti-CAV (SMSC-1) serum was served as negative and positive controls, respectively. At 5 days of incubation, 10 μl of WST-1 reagent (Roche, Germany) was added to each well, and the plates were further incubated at 37°C for 4 h in a humidified atmosphere to let the color reaction develop. Subsequently, the plates were centrifuged at 1,000×g for 10 min to remove the cells. The supernatants were transferred into new microplates and the absorbance of the samples against a background control as blank was measured at 450 nm wavelength. The mean absorbance value from the triplicates was measured for each serum dilution and the controls. Neutralizing activity was calculated as described by Lehtoranta et al. (2009) .
Splenocyte proliferation assay in the immunized chickens
At day 10 post-immunization, the chickens were sacrificed, their spleens were harvested, and splenocytes were prepared in PBS-EDTA solution (1x PBS, 2 mg/ml EDTA) supplemented with 2% penicillin/streptomycin. Red blood cells were removed using red blood cell lysis solution (0.84% NH 4 CL, 0.1% NaHCO 3 , and 1.8 ml of 5% EDTA). Splenocyte suspension was prepared in DMEM medium supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin, and viable cells were counted by trypan blue exclusion on a hemocytometer. The cells (0.1 ml at 2×10 4 cells/well) were placed into each well of 96-well plates and then incubated in triplicate with CAV VP1 antigen (3 μg), mitogen phytohemagglutinin (PHA 1 mg/ml, Sigma), or medium alone as negative control for 3 days at 37°C in an atmosphere of 5% CO 2 . The proliferation of splenocytes was evaluated by the BrdU cell proliferation assay kit (Exalpha Biologicals, USA). Data was reported as stimulation indices (SI), which was the mean of experimental wells/mean of antigen free wells (negative control). SI greater than two was considered consistent with an immunized response.
Th1 cytokines assay
The serum levels of Th1 cytokines interleukin (IL)-2, IL-12, and interferon (IFN)-γ were evaluated by commercially available chicken ELISA kits (Cusabio Biotech, USA). The assay was carried out in 96-wells microplates according to the procedures recommended by the manufacturer.
Statistical analysis
The data was analyzed by t test and statistical significance was set at P<0.05. The results were expressed as means± standard error of mean.
Results
Construction of the recombinant plasmids
Two recombinant plasmids, namely pETVP1/acmA1-VP2 and pETVP1/acmA2-VP2 were constructed. Figure 1c shows the map of the constructs. After transformation into E. coli, the constructs were verified by restriction enzyme analysis and PCR (results not shown). The sequence of the genes was confirmed by sequencing (data not shown).
Expression studies
From the crude protein extracts of both pETVP1/acmA1-VP2 and pETVP1/acmA2-VP2-transformed E. coli, the expression of VP2 gene was detected by Western blotting using monoclonal antibody to S-tag polypeptide. The VP2 protein was visualized as a single protein band with a molecular weight of about 27 kDa (Fig. 2a, b) .
Western blot analysis also confirmed the expression of the fusion proteins, VP1/AcmA1 (∼62 kDa) and VP1/ AcmA2 (∼69 kDa) using anti-His monoclonal antibody as primary antibody (Fig. 3a, b, respectively) . To explore whether the VP1 protein linked to the AcmA proteins is capable to recognize anti-CAV antibodies, when expressed synchronously with VP2, the expression of the fusion proteins were studied using the anti-CAV serum. As shown in Fig. 3c, d , anti-CAV antibodies recognized the VP1 protein linked to both AcmA1 and AcmA2 proteins which was co-expressed with the VP2 protein.
Binding of the purified fusion proteins on the cell wall surface of L. acidophilus VP1/AcmA1 and VP1/AcmA2 were purified on Ni 2+ affinity columns and mixed with a culture of L. acidophilus (ATCC 53672) as described in "Material and methods." Whole cell ELISA and immunofluorescence microscopy verified the binding of the fusion proteins on the cell wall surface.
After immunofluorescence staining, lactobacilli cells incubated with VP1/AcmA1 or VP1/AcmA2, both exhibited bright fluorescence on the cell surface (Fig. 4a, b) , indicating the presence of the fusion proteins on the cell wall surface. The control bacterial cells showed no fluorescence (Fig. 4c) .
According to the ELISA results summarized in Fig. 5 , the cells incubated with VP1/AcmA1 or VP1/AcmA2, both showed high absorption values when compared with the controls. However, the absorbance value was significantly (P<0.05) higher in the cells incubated with VP1/AcmA2 compared to those from the cells incubated with VP1/AcmA1.
Stability of the fusion proteins on the surface of L. acidophilus
The binding stability of the fusion proteins on the surface of L. acidophilus cells was tested for the duration of 5 days. As shown in Fig. 6 , the presence of the fusion proteins on the cell wall surface was detected even after a period of 5 days. No significant differences were observed in the absorbance values in this duration. In order to study whether a humoral immune response has been induced by oral immunization, serum antibody titer against CAV was tested using the IDEXX ELISA kit at days 21 (before the first feeding), 35 (2 weeks after the first feeding), and 46 (1 week after the second feeding). The antibody titers are summarized in Table 2 . Although VP1/ AcmA1-and VP1/AcmA2-vaccinated groups had no positive antibody titers to CAV at day 14 after the first feeding, both groups showed positive antibody response with titer 1,439±62 and 1,580±77, respectively 7 days after the boosted feeding. The difference in antibody titer between VP1/AcmA1 and VP1/AcmA2 groups was not 
Virus neutralizing antibody titers
The neutralization activity of the serum antibodies against CAV infection in MSB-1 cells was studied in the immunized groups. According to the results summarized in Table 2 , the tested serum samples from both VP1/ AcmA1-and VP1/AcmA2-fed groups showed positive neutralization activities against CAV with the titer of 1:128 and 1:128-1:256, respectively after the boosted administration. No neutralization activity was detected in the controls fed by the normal cells or PBS.
Serum level of Th1 cytokines in the immunized chickens
The serum level of IL-2, IL-12, and IFN-γ were analyzed before and 21 days post-immunization (7 days after the boost) by ELISA. The VP1/AcmA1-and VP1/AcmA2-immunized groups, both induced considerable levels of all three Th1 cytokines IL-2, IL-12, and IFN-γ compared to those from the controls (Fig. 7) . No significant differences were observed between the VP1/AcmA1 and VP1/AcmA2 groups in the serum levels of the cytokines.
Antigen-stimulated proliferation response of splenocytes Splenocyte proliferation assay was used to monitor T cell responses after oral immunization. At day 10 postimmunization, the spleen of the chickens was removed and the splenocytes were prepared for the assay. The cells were stimulated with the purified VP1 protein as antigenic protein from CAV. PHA was used as positive control for stimulation. As shown in Fig. 8 , a higher level of VP1 induction proliferative response (p<0.05) was observed in the VP1/AcmA1-and VP1/AcmA2-fed groups with the mean SI of 4.97 and 5.61 respectively, when compared to the control groups administrated with PBS (mean SI, 1.63) or the normal bacterial cells not carrying the fusion proteins (mean SI, 1.42). As expected, no significant difference was observed at SI between the groups when PHA was used as stimulator. These results showed the VP1-stimulated proliferative response of splenocytes in the chickens immunized with L. acidophilus cells carrying VP1/AcmA1 or VP1/AcmA2.
Discussion
In the present study, L. acidophilus (ATCC 53672) was used as live delivery vehicle for oral immunization against CAV because lactobacilli have the capacity to attach and colonize at the certain regions of the intestine that may play an important role in stimulation of both non-specific and specific immune responses against the antigens (Blomberg et al. 1993; Vaughan et al. 1999) .
Although lactobacilli seem potentially better candidates for oral immunization purposes, the number of positive results reported with Lactobacillus strains is lower in comparison to those from the lactococci (Scheppler et al. 2002; Seegers 2002) . This may be due to lower levels of antigen expression in the lactobacilli. In addition, cell wallanchored antigens have been shown to be more immunogenic compared to the cytoplasmic or secreted antigens (Wells et al. 1993; Reveneau et al. 2002) . For these reasons, the E. coli expression-based system adapted from Raha et al. (2005) was chosen to be used to display high levels of the antigen-anchor fusion proteins on the cell wall surface of L. acidophilus. In this system, target proteins can be produced as fusion proteins with an anchor motif in E. coli. These antigen-anchor motif fusions are then able to bind non-covalently onto the cell wall surface of a wide range of Gram-positive bacteria by simply mixing with the live cells. 
a Antibody titers higher than 1,000 were considered positive
The result is a live delivery vaccine that mimics pathogens with the antigenic proteins on its surface. The cell wall binding domains of the lactococcal AcmA has been shown to bind to the cell wall of a range of Grampositive bacteria, including Lactobacillus, Clostridium, Listeria, and Bacillus, when mixed to live cells (Buist 1997; Raha et al. 2005; Steen et al. 2005) . Therefore, in the present study, the cell binding domains of AcmA from L. lactis MG1363 were used as anchoring proteins to display the VP1 antigenic protein of CAV on the cell wall surface of L. acidophilus. Briefly, one or two repeats of the cell wall binding domain of AcmA were amplified and inserted into the pETDuetTM-1 to construct pETacmA1 and pETacmA2. The VP1 gene was then fused to the acmA genes to construct pETVP1/acmA1 and pETVP1/acmA2 encoding the fusion proteins, VP1/AcmA1 and VP1/AcmA2. According to the previous studies (Koch et al. 1995; Noteborn et al. 1998; Lacorte et al. 2007) , synchronous expression of the VP1 and VP2 proteins is required for the induction of neutralizing antibodies against CAV. Therefore, the VP2 gene of CAV was cloned into the second Fig. 8 Splenocyte proliferation response after oral immunization. Splenocytes from the immunized chickens were prepared and subjected to a proliferation assay using the BrdU cell proliferation assay kit. Chickens administrated with PBS or normal bacterial cells not carrying the fusion proteins were used as negative controls. Mitogen phytohemagglutinin was used as a positive control for cell proliferation. Data was reported as SI. SI greater than two was considered positive Fig. 7 Serum level of IL-2, IL-12, and IFN-γ in the vaccinated groups. The serum levels of Th1 cytokines, IL-2 (a) , and IFN-γ (c) were determined by ELISA. Chickens fed with PBS or normal cells not carrying the fusion proteins were used as controls. The results showed an increased level of all three cytokines in the VP1/AcmA1 and VP1/AcmA2-fed chickens compared with the controls MCS of the recombinant plasmids, pETVP1/acmA1 and pETVP1/acmA2 to construct pETVP1/acmA1-VP2 and pETVP1/acmA2-VP2, respectively. SDS-PAGE and Western blot analysis showed the successful expression of the binding domains of acmA gene, VP2 and the fusion proteins, VP1/AcmA1 and VP1/ AcmA2 in E. coli. Immunoblotting also showed the interaction of anti-CAV polyclonal antibodies with the VP1 protein in both fusion proteins indicating the proper structural folding of the VP1 protein to induce immune system against CAV.
L. acidophilus (ATCC 53672) isolated from chicken intestine was chosen to be used as live delivery vehicle for oral immunization in SPF chickens because mucosal colonization of lactobacilli has been proven to be host specific (Tannock et al. 1982; Lin and Savage 1984) .
The purified VP1/AcmA1 and VP1/AcmA2 were mixed with a culture of L. acidophilus followed by a binding study by using immunofluorescence staining and whole cell ELISA. Immunofluorescence staining using chicken anti-CAV serum revealed the presence of the VP1 protein on the cell surface of both bacterial groups, L. acidophilus cells incubated with VP1/AcmA1 or VP1/AcmA2. Consistent with the immunofluorescence staining results, whole cell ELISA using anti-CAV serum verified the binding of the fusion proteins on the cell wall surface of L. acidophilus. However, the ELISA absorbance value was significantly (P<0.05) higher in the VP1/AcmA2 group compared to those from the VP1/AcmA1 group suggesting that the binding capacity can be correlated with the number of the repeat domains. This view is supported by the findings of Steen et al. (2005) and Okano et al. (2008) that with an increase in the number of the binding domains of AcmA, the binding capacity of the fusion proteins on the cell surface increases.
A stability study was carried out for a period of 5 days and the result showed that the fusion proteins can be maintained on the surface of the cells in this duration. It was in agreement with the previous study by Raha et al. (2005) that the binding of the fusion proteins containing the cell wall binding domains of AcmA on the surface of Gram-positive bacteria such as Lactococcus, Lactobacillus, and Bacillus are stable for the duration of several days, when added from the outside.
The lactobacilli cells carrying the VP1 protein of CAV were used to immunize 3-week-old SPF chickens through oral route. At the age of 21 days, chickens were fed for five consecutive days and boosted with the same feeding protocol 2 weeks later. Serum antibody titer to CAV was analyzed by ELISA at days 0, 14, and 21 following the first administration. According to the ELISA results, both VP1/ AcmA1-and VP1/AcmA2-vaccinated groups showed positive antibody titer to CAV without a significant difference at day 7 following the boosted administration.
It has been indicated that neutralizing antibodies can provide complete protection to CAV infection (Yuasa et al. 1980; Rosenberger and Cloud 1998; Saif 2003; Schat 2009) . To determine the VN activity of the antibodies produced after oral immunization, the collected sera were analyzed for neutralization antibody titer against CAV infection in MSB-1 cells. The serum samples from the VP1/AcmA2-fed chickens showed positive neutralization titers ranging from 1:125 to 1:256, while the VP1/ AcmA1-fed group had a VN titer of 1:125. According to Otaki et al. (1992) , young chicks derived from immune hens against CAV with VN antibody titers as low as 1:40 can survive from the virus challenge. However, Malo and Weingarten (1995) indicated that neutralization antibody titers of at least 1:256 are necessary to prevent virus shedding in the feces and vertical transmission (Malo and Weingarten 1995) . Because of the development of age resistance to CAV during the first week of life and becoming complete within 3 weeks or even earlier (Yuasa et al. 1980; Rosenberger and Cloud 1989; Saif 2003) , the protection ability of the neutralizing antibodies produced after oral immunization was not possible to be tested. On the other hand, chickens positive for anti-CAV maternal antibodies have been shown to be protected from the disease (Yuasa et al. 1980; Vielitz and Landgraf 1988; Saif 2003) . Therefore, further study is recommended in the vaccination of breeder producing day old chicks with maternal antibodies followed by a virus challenge study.
Cell-mediated immune response was also detected after oral immunization. Positive VP1-stimulated proliferative response was observed in the splenocytes of the chickens immunized with the lactobacilli cells carrying VP1/AcmA1 or VP1/AcmA2 indicating the activation of antigen-specific immune responses in the immunized chickens. Splenocyte proliferation reaction has been shown that is directly proportional to the cell-mediated immune response (Han et al. 2000; Kim et al. 2004; Chin'ombe et al. 2009; Feng et al. 2009 ). Furthermore, administration of the VP1/AcmA1-or VP1/AcmA2-carrying lactobacilli cells were able to induce increases in the serum levels of Th1 cytokines IL-2, IL-12, and IFN-γ in the immunized chickens after 7 days postimmunization indicating that the cells carrying the VP1 protein of CAV perhaps triggered Th1 immune responses which are known to be involved in cellular-mediated immunity (Goldsby et al. 2003) .
In conclusion, consistent with the previous studies, the results of the present study showed that the binding domains of AcmA protein are capable of binding to the cell wall surface of lactobacilli when added from the outside. Furthermore, our data showed that the L. acidophilus cells carrying the VP1 protein of CAV induced immune response against CAV suggesting the use of lactobacilli as live delivery vehicle for oral immunization in chicken.
